What does 10 CFR 35 cover regarding the use of radioactive materials?

10 CFR 35 specifically addresses the medical use of by-product materials from atomic energy sources, including the use of these materials in medical applications such as diagnostic and therapeutic procedures. This regulation ensures that individuals and institutions utilizing radioactive materials for therapeutic or diagnostic purposes do so under stringent guidelines and safety standards, thereby protecting patients, medical personnel, and the general public.

The regulation outlines the responsibilities of authorized users, the licensing requirements, and the safety protocols that must be followed to minimize radiation exposure and ensure the effective use of these materials in healthcare settings. The emphasis on medical use reflects the regulation's role in facilitating the clinical applications of radioisotopes, thus improving patient outcomes while maintaining safety.

Other aspects like occupational radiation exposure, transportation, and environmental safety standards are important considerations in the broader field of radiation safety and regulatory compliance, but they fall under different sections of 10 CFR, not specifically under 10 CFR 35.